Related Experiment Video
Updated: Aug 30, 2026

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
Determinants of graft arteriosclerosis after heart transplantation
C D Scott1, I W Colquhoun, K Gould
1Cardiothoracic Centre, Freeman Hospital, Newcastle-upon-Tyne, UK.
Insights
Frequent allograft rejection episodes are linked to advanced graft coronary artery disease (TxCAD) after heart transplants. Hyperlipidemia and cytomegalovirus infection showed no association with TxCAD in this study.
Area of Science:
- Cardiology
- Transplantation Immunology
- Vascular Biology
Background:
- Accelerated graft coronary artery disease (TxCAD) is a primary limitation to long-term survival post-heart transplantation.
- Understanding factors contributing to TxCAD is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the association between rejection episodes, cytomegalovirus (CMV) infection, hyperlipidemia, and the development of TxCAD.
- To identify key risk factors for TxCAD in heart transplant recipients.
Main Methods:
- Retrospective analysis of 73 heart transplant recipients surviving at least 2 years.
- Coronary angiography performed at 2 years and annually thereafter to assess TxCAD.
- Patient records reviewed for rejection episodes and CMV infection history; lipid profiles measured post-transplant.
Main Results:
- Patients with advanced TxCAD (>70% stenoses) experienced significantly more rejection episodes in the first year (1.4 ± 1.4) compared to those without TxCAD (0.5 ± 0.8).
- No significant association was found between CMV infection or hyperlipidemia and the development of TxCAD within the first 5 years post-transplantation.
Conclusions:
- Frequent allograft rejection episodes are associated with the development of advanced TxCAD.
- Hyperlipidemia and CMV infection do not appear to be associated with TxCAD in the early post-transplant period, potentially due to prophylactic measures.
Abstract:
Accelerated graft coronary artery disease (TxCAD) is now the most common complication limiting long-term survival after heart transplantation. This study examines its association with several potentially causative factors. The study population comprised all 73 transplants recipients at this centre between May 1985 and June 1989 who survived at least 2 years. Coronary angiography was performed in every patient at 2 years after transplantation and annually thereafter. All angiograms were retrospectively examined for any evidence of TxCAD. The number of rejection episodes and history of cytomegalovirus (CMV) infection were determined from patient records. Fasting serum triglycerides, and total and HDL cholesterol were measured at between 18 and 60 months after transplantation. Patients with advanced TxCAD (> 70% stenoses) had a mean of 1.4 +/- 1.4 rejection episodes in the first year compared with 0.5 +/- 0.8 episodes in those without TxCAD (P < 0.05). The mean number of episodes in all patients with any evidence of TxCAD was 0.8 +/- 1.1 which was not significantly different from those without TxCAD. There were no association between exposure to CMV infection and TxCAD or between hyperlipidaemia and TxCAD. We conclude that frequent episodes of allograft rejection are associated with the development of advanced TxCAD. Hyperlipidaemia is not associated with the development of TxCAD in the first 5 years after transplantation. A history of exposure to CMV is not associated with TxCAD in our patients possibly because of our routine use of anti-CMV hyperimmune globulin in CMV-mismatched patients.
Related Concept Videos
Kidney Transplant I: Introduction
Coronary Artery Disease I: Introduction

